IFNG and breast carcinoma: Additionally, hyporeactive DCs isolated from breast cancer patients and stimulated ex vivo via CD40L-conditioning increase their expression of CD86 and HLA-DR, robustly secrete IL-12 and exhibit an enhanced ability to stimulate healthy T cells to proliferate and produce IFN-γ [85].